Treatment of Supraventricular Tachycardias in the New Millennium--drugs or Radiofrequency Catheter Ablation?
Overview
Authors
Affiliations
Unlabelled: Supraventricular tachycardias are a cause of significant morbidity in children. Newer anti-arrhythmic drugs and the invention of radiofrequency catheter ablation have revolutionised anti-arrhythmic therapy in children.
Conclusion: With the availability of these very effective therapeutic options, an improved knowledge of these methods and their indications is required.
Zabrodska E, Kvasilova A, Sedmera D, Olejnickova V Am J Physiol Heart Circ Physiol. 2024; 327(3):H555-H564.
PMID: 39028286 PMC: 11427115. DOI: 10.1152/ajpheart.00115.2024.
Wei N, Lamba A, Franciosi S, Law I, Ochoa L, Johnsrude C CJC Pediatr Congenit Heart Dis. 2023; 1(1):11-22.
PMID: 37969556 PMC: 10642123. DOI: 10.1016/j.cjcpc.2021.09.001.
Alotaibi R, Saleem A, Alsharef F, Alnemer Z, Saber Y, Abdelmohsen G Saudi Med J. 2022; 43(10):1111-1119.
PMID: 36261205 PMC: 9994501. DOI: 10.15537/smj.2022.43.10.20220275.
Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study.
Hinkle K, Peyvandi S, Stiver C, Killen S, Weng H, Etheridge S Pediatr Cardiol. 2017; 38(7):1317-1323.
PMID: 28664446 DOI: 10.1007/s00246-017-1662-1.
Sekarski N, Meijboom E, Di Bernardo S, Boulos Ksontini T, Mivelaz Y Eur J Pediatr. 2014; 173(8):983-96.
PMID: 24740881 DOI: 10.1007/s00431-014-2316-4.